These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31689491)

  • 1. Sickle cell disease subjects and mouse models have elevated nitrite and cGMP levels in blood compartments.
    Almeida LEF; Kamimura S; de Souza Batista CM; Spornick N; Nettleton MY; Walek E; Smith ML; Finkel JC; Darbari DS; Wakim P; Quezado ZMN
    Nitric Oxide; 2020 Jan; 94():79-91. PubMed ID: 31689491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced acute lung injury in murine models of sickle cell disease.
    Pritchard KA; Ou J; Ou Z; Shi Y; Franciosi JP; Signorino P; Kaul S; Ackland-Berglund C; Witte K; Holzhauer S; Mohandas N; Guice KS; Oldham KT; Hillery CA
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L705-14. PubMed ID: 12972407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease.
    Nath KA; Shah V; Haggard JJ; Croatt AJ; Smith LA; Hebbel RP; Katusic ZS
    Am J Physiol Regul Integr Comp Physiol; 2000 Dec; 279(6):R1949-55. PubMed ID: 11080057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase.
    Baliga RS; Milsom AB; Ghosh SM; Trinder SL; Macallister RJ; Ahluwalia A; Hobbs AJ
    Circulation; 2012 Jun; 125(23):2922-32. PubMed ID: 22572914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice.
    Almeida CB; Scheiermann C; Jang JE; Prophete C; Costa FF; Conran N; Frenette PS
    Blood; 2012 Oct; 120(14):2879-88. PubMed ID: 22833547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Nitric Oxide Donor NCX 1443: Therapeutic Effects on Pulmonary Hypertension in the SAD Mouse Model of Sickle Cell Disease.
    Abid S; Kebe K; Houssaïni A; Tomberli F; Marcos E; Bizard E; Breau M; Parpaleix A; Tissot CM; Maitre B; Lipskaia L; Derumeaux G; Bastia E; Mekontso-Dessap A; Adnot S
    J Cardiovasc Pharmacol; 2018 May; 71(5):283-292. PubMed ID: 29438213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xanthine Oxidase Drives Hemolysis and Vascular Malfunction in Sickle Cell Disease.
    Schmidt HM; Wood KC; Lewis SE; Hahn SA; Williams XM; McMahon B; Baust JJ; Yuan S; Bachman TN; Wang Y; Oh JY; Ghosh S; Ofori-Acquah SF; Lebensburger JD; Patel RP; Du J; Vitturi DA; Kelley EE; Straub AC
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):769-782. PubMed ID: 33267657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell disease in mice is associated with sensitization of sensory nerve fibers.
    Kenyon N; Wang L; Spornick N; Khaibullina A; Almeida LE; Cheng Y; Wang J; Guptill V; Finkel JC; Quezado ZM
    Exp Biol Med (Maywood); 2015 Jan; 240(1):87-98. PubMed ID: 25070860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease.
    Tchernychev B; Li H; Lee SK; Gao X; Ramanarasimhaiah R; Liu G; Hall KC; Bernier SG; Jones JE; Feil S; Feil R; Buys ES; Graul RM; Frenette PS; Masferrer JL
    Br J Pharmacol; 2021 Sep; 178(17):3463-3475. PubMed ID: 33864386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea.
    Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Winter WP; Castro O
    Br J Haematol; 2002 Dec; 119(3):855-7. PubMed ID: 12437671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
    Hsu LL; Champion HC; Campbell-Lee SA; Bivalacqua TJ; Manci EA; Diwan BA; Schimel DM; Cochard AE; Wang X; Schechter AN; Noguchi CT; Gladwin MT
    Blood; 2007 Apr; 109(7):3088-98. PubMed ID: 17158223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
    Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
    PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice.
    Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM
    PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.
    Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT
    Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers.
    Metzger IF; Sertorio JT; Tanus-Santos JE
    Acta Physiol (Oxf); 2006 Oct; 188(2):123-7. PubMed ID: 16948799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrite decreases sickle hemoglobin polymerization in vitro independently of methemoglobin formation.
    Almeida LEF; Smith ML; Kamimura S; Vogel S; de Souza Batista CM; Quezado ZMN
    Toxicol Appl Pharmacol; 2023 Aug; 473():116606. PubMed ID: 37336294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic action of nitrite in sickle cell disease.
    Wajih N; Basu S; Jailwala A; Kim HW; Ostrowski D; Perlegas A; Bolden CA; Buechler NL; Gladwin MT; Caudell DL; Rahbar E; Alexander-Miller MA; Vachharajani V; Kim-Shapiro DB
    Redox Biol; 2017 Aug; 12():1026-1039. PubMed ID: 28511346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.
    Novelli EM; Little-Ihrig L; Knupp HE; Rogers NM; Yao M; Baust JJ; Meijles D; St Croix CM; Ross MA; Pagano PJ; DeVallance ER; Miles G; Potoka KP; Isenberg JS; Gladwin MT
    Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1150-L1164. PubMed ID: 30892078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease patients in India.
    Nishank SS; Singh MP; Yadav R; Gupta RB; Gadge VS; Gwal A
    J Hum Genet; 2013 Dec; 58(12):775-9. PubMed ID: 24088668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome.
    Sullivan KJ; Kissoon N; Sandler E; Gauger C; Froyen M; Duckworth L; Brown M; Murphy S
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):e249-58. PubMed ID: 20724949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.